Pro Medicus (ASX:PME) Insider Purchases A$46,572.00 in Stock

Pro Medicus Limited (ASX:PME) insider Peter Kempen purchased 400 shares of Pro Medicus stock in a transaction that occurred on Monday, February 23rd. The stock was purchased at an average price of A$116.43 per share, with a total value of A$46,572.00.

Peter Kempen also recently made the following trade(s):

• On Monday, December 29th, Peter Kempen acquired 600 shares of Pro Medicus stock. The stock was purchased at an average cost of A$224.00 per share, for a total transaction of A$134,400.00.

Pro Medicus Price Performance

The firm has a market capitalization of $29.16 billion, a P/E ratio of 351.99, a PEG ratio of 3.87 and a beta of 0.56. The company has a debt-to-equity ratio of 1.10, a quick ratio of 4.39 and a current ratio of 5.98.

Pro Medicus Dividend Announcement

The company also recently disclosed a Interim dividend, which will be paid on Thursday, March 19th. Stockholders of record on Thursday, March 19th will be paid a $0.32 dividend. This represents a dividend yield of 27.0%. The ex-dividend date of this dividend is Wednesday, February 25th. Pro Medicus’s dividend payout ratio is currently 56.41%.

Pro Medicus Company Profile

Pro Medicus Limited engages in the development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups, and other related health entities in Australia, North America, and Europe. The company offers Visage radiology information systems (RIS), a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform. It also provides healthcare imaging software that provides radiologists and clinicians with visualization capability for viewing 2-D, 3-D, and 4-D medical images, as well as picture archive and communication system (PACS)/digital imaging software; and integration products.